EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Subclinical psoriatic arthritis: concepts, dilemmas, and research needs

Fadi Kharouf, Pankti Mehta, Virginia Carrizo Abarza, Richard J Cook, Vinod Chandran, Denis Poddubnyy

Annals of the Rheumatic Diseases · 2026-08 · 85 (8) · 1445-1449

DOI: 10.1016/j.ard.2026.03.011 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of the Rheumatic Diseases, 2026-08. Verfasst von Fadi Kharouf und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gladman Krembil Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, University Health…. Hauptthemen laut MEDLINE: Arthritis, Psoriatic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Krembil Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriatic arthritis (PsA) develops in up to one-third of patients with psoriasis (PsC), yet increasing attention is now focused on a putative subclinical phase preceding overt arthritis. Several conceptual frameworks describe the PsC-PsA transition, including the pragmatic definition proposed by the European Alliance of Associations for Rheumatology, which defines subclinical PsA as arthralgia and/or imaging abnormalities in the absence of clinical synovitis. However, the absence of validated serological biomarkers, the marked clinical heterogeneity of PsA, the frequent occurrence of nonspecific musculoskeletal symptoms, and the limited specificity of imaging findings complicate risk stratification and may lead to misclassification and overtreatment. Lessons from rheumatoid arthritis highlight both the potential and the pitfalls of applying prevention paradigms to subclinical disease. This viewpoint critically appraises current definitions of subclinical PsA, discusses therapeutic and trial-design implications, and outlines key research priorities, including longitudinal PsC cohorts, advanced and molecular imaging, and multiomic biomarker discovery. Future progress depends on developing robust risk-stratification models that capture the full spectrum of psoriatic disease and enable targeted prevention strategies while minimising unnecessary intervention. At the same time, caution is warranted against broad expansion of the 'subclinical' disease state concept, as it may dilute disease definitions, increase overdiagnosis, and divert attention from improving early and accurate identification of clinically meaningful PsA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, PsoriaticHumansBiomarkersAsymptomatic Diseases

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Gladman Krembil Psoriatic Arthritis Program, Centre for Prognosis Studies in the Rheumatic Diseases, Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada; Division of Rheumatology, Department of…
  • Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada.

Förderung

  • Krembil Foundation

Zitieren

APA

Kharouf, F., Mehta, P., Carrizo Abarza, V., Cook, R. J., Chandran, V., & Poddubnyy, D. (2026). Subclinical psoriatic arthritis: concepts, dilemmas, and research needs. Annals of the Rheumatic Diseases, 85(8), 1445-1449. https://doi.org/10.1016/j.ard.2026.03.011

Vancouver

Kharouf F, Mehta P, Carrizo Abarza V, Cook RJ, Chandran V, Poddubnyy D. Subclinical psoriatic arthritis: concepts, dilemmas, and research needs. Annals of the Rheumatic Diseases. 2026;85(8):1445-1449. doi:10.1016/j.ard.2026.03.011

BibTeX
@article{Kharouf2026,
  author = {Kharouf, Fadi and Mehta, Pankti and Carrizo Abarza, Virginia and Cook, Richard J and Chandran, Vinod and Poddubnyy, Denis},
  title = {Subclinical psoriatic arthritis: concepts, dilemmas, and research needs},
  journal = {Annals of the Rheumatic Diseases},
  year = {2026},
  volume = {85},
  number = {8},
  pages = {1445--1449},
  doi = {10.1016/j.ard.2026.03.011}
}
Kostenlos starten →